Sharma Smriti, Davis Richard E, Srivastva Shweta, Nylén Susanne, Sundar Shyam, Wilson Mary E
Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.
Interdisciplinary Program in Immunology, University of Iowa.
J Infect Dis. 2016 Nov 15;214(10):1531-1538. doi: 10.1093/infdis/jiw394. Epub 2016 Sep 6.
Visceral leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and impaired protective T-cell responses against the parasite.
Peripheral blood leukocytes from 105 subjects with VL and healthy control subjects from the endemic region of Muzaffarpur, Bihar, India, were compared using flow cytometry and reverse-transcriptase quantitative polymerase chain reaction. Findings were correlated with clinical data.
An expanded population of low-density neutrophils that expressed HLA-DR, CD80 and CD86 was observed in subjects with VL. This neutrophil population contracted after successful treatment of disease. Plasma from patients with acute VL was able to induce similar high-level HLA-DR expression in neutrophils from healthy subjects. HLA-DR neutrophils from subjects with VL did not stimulate T-cell proliferation, but they did express higher programmed cell death ligand-1 (PDL1) than other neutrophils, and lymphocytes of the same subjects expressed high programmed cell death 1 (PD1).
Patients with acute VL have expanded circulating low-density neutrophils expressing markers of antigen presentation, which diminish after treatment. Development of HLA-DR neutrophils is stimulated, at least in part, by components of plasma from patients with acute disease. Although we found no evidence that they act as antigen-presenting cells, these neutrophils expressed markers implicating a role in T-cell exhaustion.
内脏利什曼病(VL)是一种潜在的致命性寄生虫病,与发热、恶病质以及针对该寄生虫的保护性T细胞反应受损有关。
使用流式细胞术和逆转录定量聚合酶链反应,对来自印度比哈尔邦穆扎法尔布尔流行地区的105名VL患者和健康对照者的外周血白细胞进行比较。研究结果与临床数据相关联。
在VL患者中观察到表达HLA-DR、CD80和CD86的低密度中性粒细胞群体扩大。疾病成功治疗后,这一中性粒细胞群体收缩。急性VL患者的血浆能够诱导健康受试者中性粒细胞中出现类似的高水平HLA-DR表达。VL患者的HLA-DR阳性中性粒细胞不刺激T细胞增殖,但它们表达的程序性细胞死亡配体-1(PDL1)高于其他中性粒细胞,且同一受试者的淋巴细胞表达高水平的程序性细胞死亡蛋白1(PD1)。
急性VL患者循环中表达抗原呈递标志物的低密度中性粒细胞增多,治疗后减少。急性疾病患者血浆中的成分至少部分刺激了HLA-DR阳性中性粒细胞的产生。尽管我们没有发现证据表明它们作为抗原呈递细胞发挥作用,但这些中性粒细胞表达的标志物表明其在T细胞耗竭中起作用。